Individuals possessing private health coverage might face escalated expenses for medical procedures or examinations conducted within hospital settings.
A study released on Monday by the research entity Rand Corp. revealed that during 2022, the fees hospitals invoiced to private and employer-sponsored insurance entities were, on average, 254% greater than the corresponding charges Medicare would have applied for identical services.
Stacie Dusetzina, a professor specializing in health policy at Vanderbilt University in Nashville, Tennessee, who was not engaged in the study, expressed, "These excessively high reimbursements ultimately lead to elevated premiums for health insurance coverage and can result in individuals seeking medical attention having to grapple with exorbitant costs to receive it."
The latest revelations stemmed from an examination of health insurance claims data originating from over 4,000 hospitals spanning 49 states and Washington, D.C., spanning the years 2020 through 2022. This encompassed both inpatient and outpatient medical services. In total, the analysis delved into approximately 6% of the total payouts by private insurance to hospitals during the stated timeframe.
Brian Briscombe, a healthcare expenditure analyst at Rand Corp. overseeing the report, remarked that the lofty charges levied on private insurers effectively translate to increased financial burdens on patients, either directly through heightened copays or out-of-pocket disbursements, or indirectly through diminished earnings.
Briscombe highlighted, "Around 160 million individuals in the U.S. procure their health insurance via their employment. When you analyze it through an economic lens, it all ultimately gets shouldered by the patient. I mean, if it cost my employer half as much to provide healthcare coverage, my salary would see an uptick."
In 2022, the costs incurred for hospital services constituted 42% of healthcare expenditures for individuals with private health insurance, with escalations in hospital fees serving as a notable contributor to the escalation in average expenditure per individual.
The study unveiled considerable discrepancies in hospital pricing across states.
Hospitals in Arkansas, Iowa, Massachusetts, Michigan, and Mississippi billed private insurance at rates below 200% of Medicare rates.
Conversely, hospitals in California, Florida, Georgia, New York, South Carolina, West Virginia, and Wisconsin invoiced private insurance at rates exceeding 300% of Medicare rates.
Furthermore, the report discovered that hospitals frequently imposed higher charges for prescription medications administered by healthcare practitioners, compared to rates for the same medications dispensed within analogous settings, such as a physician's office.
Briscombe attributed these disparities in pricing to the substantial pricing leverage wielded by hospitals. In instances where a hospital enjoys limited competition within a given region, it often possesses the latitude to set prices at its discretion.
Cynthia Cox, a vice president at KFF, a research organization focusing on health policy issues, pointed out that Medicare often disburses lower sums partly due to its superior bargaining power with hospitals. The majority of Medicare beneficiaries are elderly individuals with underlying health conditions, constituting a sizable proportion of hospital revenue.
Molly Smith, group vice president for policy at the American Hospital Association, the industry's trade body, dismissed the report's findings as "a biased and incomplete depiction of hospital expenditures."
According to a report published by AHA in January, Medicare "significantly" undercompensated hospitals for the expenses associated with patient care in 2022.
For every dollar expended by hospitals in caring for Medicare patients, they received only 82 cents in reimbursement, the report asserted. Cumulatively, Medicare underpayments totaled $99.2 billion.
Dusetzina, from Vanderbilt University, underscored the consistency of the Rand report's findings with earlier studies indicating that private insurance often entails higher charges.
"The one advantage for individuals covered by commercial insurance is the presence of out-of-pocket limits for in-network care. Therefore, even if the prices are exorbitant, as long as the facilities where they receive care fall within the network, there exists an upper cap on their financial outlay," she elucidated.
Cox emphasized the mounting call for enhanced pricing transparency from hospitals, enabling insurers to negotiate for reduced rates and enabling patients to seek more favorable options.
Although a federal regulation from the Centers for Medicare and Medicaid Services mandates hospitals to disclose their pricing, reports have demonstrated scant compliance with the stipulation.
Cox elucidated that pricing transparency can prove somewhat convoluted as the precise cost of a service and the rationale behind it are not always apparent.
"It's not invariably evident from perusing price transparency data exactly how much compensation is being remitted," she remarked. "For instance, you might observe that an MRI appears to cost 20 cents, but in reality, it's 20% of some other figures."
Briscombe reiterated that the objective of the Rand report is to empower and enlighten employers and patients.
"When you contemplate the price of anything, be it a luxury car, the question arises, 'Is it overpriced?'" he pondered. "Well, the sole arbiter of that judgment is the purchaser."
